These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19149035)

  • 1. [Antirheumatic agents for treatment of rheumatoid arthritis].
    Yamanaka H
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2399-404. PubMed ID: 19149035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disease modifying anti-rheumatic drugs (DMARDs): an overview].
    Kawabata D; Mimori T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():489-92. PubMed ID: 15799404
    [No Abstract]   [Full Text] [Related]  

  • 3. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
    Krüger K
    Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effects of DMARDs in treatment of rheumatoid arthritis].
    Sugii S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():566-72. PubMed ID: 15799419
    [No Abstract]   [Full Text] [Related]  

  • 5. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2009 Mar; 19(3):395-403. PubMed ID: 19252250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can a combination therapy with leflunomide be recommended for patients with active rheumatoid arthritis?].
    Hamann F
    Z Rheumatol; 2003 Apr; 62(2):204-5. PubMed ID: 12820624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 10. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lefunomide in combination therapy.
    Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide in combination therapy for rheumatoid arthritis.
    Savage RL
    Drug Saf; 2010 Jun; 33(6):523-6. PubMed ID: 20486733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leflunomide + methotrexate combination therapy from the physician's viewpoint].
    Reinhold-Keller E; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):191-3. PubMed ID: 12056299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy and malpractice exemplified by combination leflunomide and methotrexate therapy].
    Burgardt C
    Z Rheumatol; 2002 Apr; 61(2):189-90. PubMed ID: 12056298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of leflunomide].
    Hirohata S
    Nihon Rinsho; 2002 Dec; 60(12):2357-63. PubMed ID: 12510362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM
    Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
    Tamura N
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2873-9. PubMed ID: 23214096
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leflunomide--a new disease modifying anti-rheumatic agent].
    Rødevand E; Kvien TK; Johnsen V
    Tidsskr Nor Laegeforen; 2001 Nov; 121(27):3181-4. PubMed ID: 11876141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.